Molecular Mechanics And Drug Docking Studies On Klebsheilla Pneumonia (Multidrug Efflux System Protein) using Insilico Protocols

International Journal of Novel Trends in Pharmaceutical Sciences,2012,2,2,82-89.
Published:June 2012
Type:Research Article
Authors:
Author(s) affiliations:

Hepzibah. W1*, John WilliamS1 and Balaji. M2

1Department of Advanced Zoology and Biotechnology, (SECNARM), Loyola College, Chennai-34, Tamilnadu, India.

2Director, Akshaya Neuroinformatics Research Center, Chennai-5, Tamilnadu, India.

Abstract:

Klebsiella pneumonia is a necrotizing process with a predilection for debilitated people. It has a high mortality rate of approximately 50% even with antimicrobial therapy. The mortality rate approaches 100% for persons with alcoholism and bacteremia. Klebsiella bacteremia and sepsis produce clinical manifestations similar to those caused by other gram-negative enteric organisms. Morbidity and mortality rates are comparable to those for other gram-negative organisms that cause sepsis and septic shock. In neonatal units, outbreaks caused by ESBL-producing strains present a more serious problem and may be associated with increased mortality .The primary aim of the present research investigation is to find out whether the best plant extract compound inhibits the potential Human pathogens using in-silico methods.

Downloads: 
In-page image(s): 

Molecular docking Klebsheilla pneumonia (multidrug efflux system protein) and Rutin